Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome.
Durrani J, Awada H, Kishtagari A, Visconte V, Kerr C, Adema V, Nagata Y, Kuzmanovic T, Hong S, Patel B, Nazha A, Lichtin A, Mukherjee S, Saunthararajah Y, Carraway H, Sekeres M, Maciejewski JP. Durrani J, et al. Among authors: saunthararajah y. Leukemia. 2020 Mar;34(3):957-962. doi: 10.1038/s41375-019-0601-y. Epub 2019 Oct 17. Leukemia. 2020. PMID: 31624375 Free PMC article. No abstract available.
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N, Konopleva M, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. Levitz D, et al. Among authors: saunthararajah y. Clin Cancer Res. 2023 Aug 1;29(15):2774-2780. doi: 10.1158/1078-0432.CCR-23-0842. Clin Cancer Res. 2023. PMID: 37341641
Differentiation impairment and the evolution of MDS.
Mahmud N, Saunthararajah Y. Mahmud N, et al. Among authors: saunthararajah y. Leuk Lymphoma. 2007 Jul;48(7):1267-8. doi: 10.1080/10428190701441778. Leuk Lymphoma. 2007. PMID: 17613753 No abstract available.
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP. Jiang Y, et al. Among authors: saunthararajah y. Blood. 2009 Feb 5;113(6):1315-25. doi: 10.1182/blood-2008-06-163246. Epub 2008 Oct 2. Blood. 2009. PMID: 18832655 Free PMC article.
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.
Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, Egorin MJ, Lim K, Cotta CV, Price C, Kalaycio M. Advani AS, et al. Among authors: saunthararajah y. Leuk Res. 2010 Dec;34(12):1622-6. doi: 10.1016/j.leukres.2010.03.021. Epub 2010 Apr 27. Leuk Res. 2010. PMID: 20427086 Clinical Trial.
Race and intensity of post-remission therapy in acute myeloid leukemia.
Brady AK, Fu AZ, Earl M, Kalaycio M, Advani A, Saunthararajah Y, Sobecks R, Copelan E, Sekeres MA. Brady AK, et al. Among authors: saunthararajah y. Leuk Res. 2011 Mar;35(3):346-50. doi: 10.1016/j.leukres.2010.07.020. Epub 2010 Aug 8. Leuk Res. 2011. PMID: 20696474
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
Bejanyan N, Tiu RV, Raza A, Jankowska A, Kalaycio M, Advani A, Chan J, Saunthararajah Y, Mooney L, Maciejewski JP, Sekeres MA. Bejanyan N, et al. Among authors: saunthararajah y. Cancer. 2012 Aug 15;118(16):3968-76. doi: 10.1002/cncr.26741. Epub 2011 Dec 16. Cancer. 2012. PMID: 22180010 Free article. Clinical Trial.
Polycomb segment myeloid malignancies.
Saunthararajah Y, Maciejewski J. Saunthararajah Y, et al. Blood. 2012 Feb 2;119(5):1097-8. doi: 10.1182/blood-2011-12-391268. Blood. 2012. PMID: 22308277 Free article.
163 results